Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma

Clinical trial NCT00715013 · COMPLETED

Trial details

NCT number: NCT00715013
Sponsor: University of Zurich
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma Planned for Reoperation

Start date: 2008-07-01
Primary completion: 2010-12-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.